Title:
PHARMACEUTICAL COMPOSITION COMPRISING THYMIDINE PHOSPHORYLASE (TYMP) PROTEIN AS EFFECTIVE INGREDIENT FOR PREVENTION OR TREATMENT OF HAIR LOSS
Document Type and Number:
WIPO Patent Application WO/2018/030683
Kind Code:
A1
Abstract:
The present invention relates to a composition comprising a TYMP protein as an effective ingredient for prevention, treatment, or alleviation of hair loss and for promotion of hair growth and hair development. A composition comprising a TYMP protein as an effective ingredient for prevention of hair loss and promotion of hair growth according to the present invention shows an outstanding hair growth effect within a short time without side effects upon use in the treatment of hair loss and thus can be effectively used as a drug as well as in quasi-drugs, cosmetics, and health functional foods.
Inventors:
SONG SUN UK (KR)
SUNG JONG HYUK (KR)
SUNG JONG HYUK (KR)
Application Number:
PCT/KR2017/008117
Publication Date:
February 15, 2018
Filing Date:
July 27, 2017
Export Citation:
Assignee:
SCM LIFESCIENCE CO LTD (KR)
International Classes:
A61K38/17; A23L33/18; A61K8/64; A61Q7/00
Domestic Patent References:
| WO1993008273A1 | 1993-04-29 |
Foreign References:
| KR20140146062A | 2014-12-24 | |||
| JP2003513619A | 2003-04-15 | |||
| KR20160005781A | 2016-01-15 | |||
| KR101671361B1 | 2016-11-01 |
Other References:
PUGLISI, F.: "Thymidine phosphorylase expression is associated with time to progression in patients receiving low-dose, docetaxel-modulated capecitabine for metastatic breast cancer", ANNALS OF ONCOLOGY, vol. 19, no. 9, September 2008 (2008-09-01), pages 1541 - 1546, XP055603508, ISSN: 0923-7534, DOI: 10.1093/annonc/mdn165
Attorney, Agent or Firm:
KIM, Soon Woong (KR)
Download PDF: